Related Experiment Video
Updated: Oct 16, 2026

An Ex vivo Model to Study Hormone Action in the Human Breast
Published on: January 8, 2015
The loss of estrogen and progesterone receptor gene expression in human breast cancer
R G Lapidus1, S J Nass, N E Davidson
1The Johns Hopkins Oncology Center, Baltimore, Maryland 21231, USA.
Abstract:
Hormone responsiveness is a critical determinant of breast cancer progression and management, and the response to endocrine therapy is highly correlated with the estrogen receptor (ER)3 and progesterone receptor (PR) status of tumor cells. Thus, key areas of study in breast cancer are those mechanisms that regulate ER and PR expression in normal and malignant breast tissues. One-third of all breast cancers lack ER and PR; these conditions are associated with less differentiated tumors and poorer clinical outcome. In addition, approximately one-half of ER-positive tumors lack PR protein and patients with this phenotype are less likely to respond to hormonal therapies than those whose tumors express both receptors. Since PR is induced by ER; its presence is a marker of a functional ER. In this review, we will discuss possible mechanisms for loss of ER and PR gene expression, especially structural changes within each gene including deletions, polymorphisms or methylation. Improved understanding of the pathways that lead to loss of ER and/or PR proteins should allow the development of better predictive indicators as well as novel therapeutic approaches to target these hormone-independent cancers.
Insights
Understanding estrogen receptor (ER) and progesterone receptor (PR) loss in breast cancer is crucial. This review explores mechanisms behind ER/PR deficiency, impacting treatment and outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hormone responsiveness dictates breast cancer progression and endocrine therapy response.
- Estrogen receptor (ER) and progesterone receptor (PR) status are key determinants.
- Loss of ER/PR expression is linked to aggressive tumors and poor outcomes.
Purpose of the Study:
- To review mechanisms regulating ER and PR expression in breast cancer.
- To investigate causes of ER and PR loss, including genetic alterations.
- To identify pathways leading to hormone-independent breast cancers.
Main Methods:
- Review of existing literature on ER/PR regulation and loss in breast cancer.
- Discussion of genetic mechanisms such as deletions, polymorphisms, and methylation.
- Analysis of the functional relationship between ER and PR expression.
Main Results:
- Approximately one-third of breast cancers lack both ER and PR.
- Half of ER-positive tumors lack PR, indicating a non-functional ER pathway.
- PR induction by ER serves as a marker for functional ER signaling.
Conclusions:
- Understanding ER/PR loss mechanisms is vital for breast cancer management.
- Identifying pathways of ER/PR deficiency can lead to better predictive markers.
- Novel therapeutic strategies may target hormone-independent breast cancers.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle
Epigenetic Regulation
X-chromosome...
